A randomized, open-label clinical trial comparing the long-term effects of miltefosine and meglumine antimoniate for mucosal leishmaniasis
INTRODUCTION: The treatment of mucosal leishmaniasis (ML) is difficult due to the toxicity and route of administration of standard drugs. Miltefosine is an oral agent used for leishmaniasis treatment; however, no data exist regarding its use for ML in Brazil. In this study, we aimed to evaluate the...
| Main Authors: | Sampaio, Raimunda Nonata Ribeiro, Silva, Juliana Saboia Fontenele e, Paula, Carmen Dea Ribeiro de, Porto, Cláudia, Motta, Jorgeth de Oliveira Carneiro da, Pereira, Ledice Inacia de Araujo, Martins, Sofia Sales, Barroso, Daniel Holanda, Freire, Gustavo Subtil Magalhães, Gomes, Ciro Martins |
|---|---|
| Format: | Artigo |
| Language: | English |
| Published: |
Sociedade Brasileira de Medicina Tropical - SBMT
2020
|
| Subjects: | |
| Online Access: |
https://repositorio.unb.br/handle/10482/36245 https://doi.org/10.1590/0037-8682-0292-2018 http://orcid.org/0000-0002-8223-0058 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
